3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions

Image source Getty Images Roughly 90 of drugs in clinical trials never make it to the Food and Drug Administration for review so it s not surprising that a green light can be a market moving event especially when it s granted to drugs targeting billion dollar blockbuster